Market cap
₹40 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
40 | 18,183 | 15,288 | 12,380 | 7,159 |
Revenue (₹ Cr) |
2 | 6,643 | 14,593 | 38,840 | 926 |
Net Profit (₹ Cr) |
-2.49 | 804.37 | 1,434.33 | 1,227.53 | 35.13 |
Net Margin (%) |
-105.39 | 11.74 | 9.69 | 3.14 | 3.76 |
RoE (%) |
-0.93 | 13.10 | 16.37 | 16.62 | 4.40 |
Price to Earnings |
-- | 22.86 | 10.67 | 26.63 | 201.32 |
Price-To-Book |
0.15 | 2.81 | 1.82 | 1.37 | 4.49 |
Income Statement (₹ Cr)
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1.31 | 5,583.35 | 12,077.35 | 31,608.61 | 777.56 |
|
Total Income
|
2.51 | 5,692.38 | 12,226.59 | 32,047.76 | 781.57 |
|
Total Expenditure
|
2.14 | 4,670.39 | 10,754.19 | 29,001.39 | 641.24 |
|
EBITDA
|
-0.82 | 912.96 | 1,323.16 | 2,607.22 | 136.32 |
|
Depreciation
|
1.93 | 316.82 | 410.17 | 512.39 | 27.79 |
|
EBIT
|
-2.75 | 596.14 | 912.99 | 2,094.83 | 108.53 |
|
Interest
|
0.02 | 23.98 | 152.82 | 372.43 | 48.50 |
|
Other Income
|
1.19 | 109.03 | 149.24 | 439.15 | 4.01 |
|
Exceptional Items
|
-- | -- | -- | 346.77 | -14.08 |
|
Profit before Tax
|
-1.58 | 692.49 | 909.41 | 2,454.59 | 50.16 |
|
Provision for Tax
|
-- | 193.66 | 305.14 | 682.05 | 15.33 |
|
Profit after Tax
|
-1.58 | 498.83 | 604.27 | 1,772.54 | 34.83 |
Liabilities (₹ Cr)
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
268.04 | 5,598.55 | 7,004.13 | 7,935.73 | 789.39 |
|
Minority Interest
|
-- | 63.82 | -- | 4,995.79 | -- |
|
Non-Current Liabilities
|
175.67 | 435.84 | 2,483.85 | 1,044.59 | 224.52 |
|
Current Liabilities
|
0.55 | 1,036.89 | 5,280.02 | 10,394.98 | 733.40 |
|
Total Liabilities
|
444.26 | 7,135.10 | 14,774.14 | 24,371.09 | 1,747.31 |
Assets (₹ Cr)
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
443.57 | 4,037.12 | 7,617.51 | 8,052.50 | 747.48 |
|
Current Assets
|
0.69 | 3,097.98 | 7,136.18 | 16,318.37 | 999.83 |
|
Total Assets
|
444.26 | 7,135.10 | 14,774.14 | 24,371.09 | 1,747.31 |
|
Total Debt*
|
175.46 | 197.69 | 2,408.19 | 2,121.01 | 566.04 |
|
Net Current Assets
|
0.13 | 2,061.09 | 1,856.16 | 5,923.39 | 266.43 |
|
Contingent Liabilities
|
5.64 | 162.18 | 19.49 | 459.30 | 28.70 |
Cashflow (₹ Cr)
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.50 | 603.13 | 1,126.96 | 1,936.39 | 195.98 |
|
Cash Flow from Investing Activities
|
1.33 | -495.09 | -849.80 | -2,782.30 | -316.59 |
|
Cash from Financing Activities
|
0.04 | -117.78 | -0.53 | 73.84 | 113.07 |
|
Net Cash Inflow / Outflow
|
-0.12 | -9.74 | 276.63 | -772.07 | -7.54 |
Ratios
Profitability Ratios
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-0.35 | 12.86 | 11.79 | 30.76 | 7.86 |
|
ROE (%)
|
-0.59 | 9.31 | 8.94 | 23.70 | 4.50 |
|
ROA (%)
|
-0.35 | 7.27 | 4.28 | 7.73 | 2.17 |
|
EBIT Margin (%)
|
28.18 | 18.30 | 12.19 | 9.64 | 18.05 |
|
Net Margin (%)
|
-62.91 | 8.76 | 4.94 | 5.53 | 4.46 |
|
Cash Profit Margin (%)
|
26.57 | 14.28 | 7.74 | 7.23 | 8.01 |
Growth Ratios
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
221.09 | 18.15 | 10.57 | 7.46 | 12.58 |
|
EBIT Growth (%)
|
239.53 | 47.07 | 35.18 | 4.35 | 19.41 |
|
Net Profit Growth (%)
|
28.10 | 53.90 | 35.15 | 9.58 | -2.30 |
|
EPS Growth (%)
|
28.12 | 49.81 | 35.15 | -2.53 | -2.30 |
|
Book Value Growth (%)
|
-0.58 | 9.47 | 7.39 | 12.47 | 3.83 |
Valuation Ratios
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 37.31 | 27.75 | 15.90 | 117.02 |
|
Price / Book Value
|
0.21 | 3.23 | 2.39 | 1.76 | 5.16 |
|
Dividend Yield (%)
|
0.00 | 0.41 | 0.84 | 0.00 | 0.06 |
|
EV/EBITDA
|
627.67 | 17.80 | 12.35 | 4.07 | 33.04 |
|
Market Cap (₹ Cr)
|
56.98 | 18,057.11 | 16,766.99 | 13,964.68 | 4,075.97 |
Solvency Ratios
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.65 | 0.04 | 0.34 | 0.27 | 0.72 |
|
Short term debt to equity ratio
|
-- | 0.00 | 0.12 | 0.22 | 0.45 |
|
Current Ratio
|
1.24 | 2.99 | 1.35 | 1.57 | 1.36 |
|
Quick Ratio
|
0.37 | 2.28 | 0.82 | 0.93 | 0.94 |
|
Interest Coverage
|
-73.39 | 29.88 | 6.95 | 7.59 | 2.03 |
Operating Efficiency Ratios
| SVC | Atul | DCM Shriram | EID Parry | Neogen Chemicals | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.59 | 20.17 | 7.61 | 5.56 | 25.75 |
|
Asset Turnover
|
0.00 | 0.83 | 0.93 | 1.38 | 0.49 |
|
Receivable days
|
3.75 | 65.62 | 21.80 | 20.74 | 112.52 |
|
Inventory Days
|
67.01 | 43.06 | 76.27 | 78.72 | 161.47 |
|
Payable days
|
285.02 | 79.37 | 64.58 | 39.02 | 175.91 |
|
Cash Conversion Cycle
|
-214.26 | 29.31 | 33.49 | 60.44 | 98.08 |